U.S. Oversight Enabled Wuhan Gain‑of‑Function

The White House page argues that U.S. funding and weak oversight (NIH grants to EcoHealth Alliance) helped enable risky coronavirus research in Wuhan and that subsequent agency delays, document deletions, and obstruction obscured the investigatory trail. It also points to administrative actions (funding suspension, debarment proceedings, Department of Justice inquiry) as evidence of oversight breakdowns. — If true, the claim reframes pandemic origins as a failure of domestic grant governance and national‑security policy, pushing debate toward institutional reform, transparency, and international inspection regimes.